Navigation Links


Euk at Biology News

Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine

When the most common adult leukemia in the United States was last reviewed by the New England Journal of Medicine (NEJM) in 1995, it was seen through the eyes of theories that dated back to the 1960s. As such, the journal recently invited three of the world's foremost experts on chronic lymphocytic leukemia (CLL) to write an authoritative update covering the transformation in the scientific commu...

Genome-wide mouse study yields link to human leukemia

Thanks to a handful of very special mice, scientists have discovered a new tumor suppressor gene and a unique chemical signature implicated in the development of human leukemia, findings that open up a "treasure box" of opportunity and possibility, study authors say. Researchers in The Ohio State University Comprehensive Cancer Center bred a type of mouse that develops acute lymphoblastic...

Leukemia Drug Breakthrough Study In New England Journal Of Medicine

Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia. Given in pill form, Revlimid simultaneously blocks the growth of new blood vessels th...

Enzyme allows B cells to resist death, leading to leukemia

B cell chronic lymphocytic leukemia (B-CLL)is the most common leukemia in adults and is characterized by theprogressive accumulation of mature B lymphocytes in the blood, bonemarrow, and lymphatic tissues. It is believed that in the early stagesof disease, B-CLL is the result of an undefined defect in theprogrammed signals that trigger normal B cell death (apoptosis). LivioTrentin and colle...

Genetically modified natural killer immune cells attack, kill leukemia cells

Natural killer (NK) immune system cells can be genetically modified to brandish a powerful "on-switch" that prompts them to aggressively attack and kill leukemic cells. This finding, from researchers at St. Jude Children's Research Hospital, suggests a way to improve the outcome of children who receive treatment for acute lymphoblastic leukemia (ALL) or other blood cancers. Results of the...

More>>

Euk at Biology Products

Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Peripheral blood leukocyte from OriGene Technologies

Description:The Rapid-Screen cDNA Library Panels were designed for full-length gene cloning and require just three sets of PCRs to identify the desired cDNA clone. The first PCR analysis is performed in a 96-well "Master Plate," where each well contains plasmid DNA from 5,000 clones. Having identified the positive well(s) by gel electrophoresis of the reaction products, the second PCR analysis is carried out...
Company:OriGene Technologies

Leukocytes, human - sonicated from AppliChem GmbH

Description:NOTE: 0.9 ml per liter of urine will give a positive reaction for leukocytes on an Ames or BMD dipstick. Certification: The Donors are of US origin and have been tested and found to be NEGATIVE for HbsAg, HCV, HIV-1 & 2, Syphilis and HIV-1 Antigen by currently approved FDA methods. THIS MATERIAL IS SOLD FOR IN-VITRO DIAGNOSTIC USE ONLY IN MANUFACTURING OR RESEARCH. THIS MATERIAL IS NOT SUI...
Company:AppliChem GmbH

OPTIMIX KIT FOR EUKARYOTE from Thermo Scientific

Description:OptiBuffer is a fully optimised medium, designed forthe electroporation of eukaryotic cells. OptiBufferimproves both transfection efficiencies and survivalrates over PBS or other standard culture media....
Company:Thermo Scientific

Gene Pulser Xcell Eukaryotic System from Bio-Rad

Description:The Gene Pulser Xcell eukaryotic system, 100 to 240 V, 50-60 Hz, is used for electroporation of mammalian cells. This system includes the main unit, CE module for exponential (25-3,275 microfarad range) or square-wave pulses, ShockPod shocking chamber, 5 sterile cuvettes (0.4 cm gap), and instructions....
Company:Bio-Rad

FRT flanked, Pro and Euk. Neomycin Selection Cassette (FRT-PGK-gb2-neo-FRT) from Gene Bridges GmbH

Description:The with a eukaryotic promoter (PGK) for expression of neomycin resistance in mammalian cell...
Company:Gene Bridges GmbH

More>>

Euk at Biology Technology

Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells

<A href="http://www.biocompare.com/techart.asp?id=575">Actinobacillus pleuropnomoniae <A href="http://www.biocompare.com/techart.asp?id=576">Actinomyces viscosus <A...

Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells

<A href="http://www.biocompare.com/techart.asp?id=575">Actinobacillus pleuropnomoniae <A href="http://www.biocompare.com/techart.asp?id=576">Actinomyces viscosus <A...

Simple and Rapid Isolation of Plant RNA Using the Eppendorf Perfect RNA, Eukaryotic, Maxi Kit

Simple and Rapid Isolation of Plant RNA Using the Eppendorf Sonja Vorwerk, Max Planck Institut fr Zchtungsforschung, Carl-von-Linn Weg 10, 50829 Cologne, Germany Phone: ++49-221-5062-441, Fax. ++49-221-5062-413, e-mai...

Bacterial RNA Isolation From Infected Eukaryotic Hosts

90% of mammalian RNA from complex mixtures of host-bacterial samples Seamless integration with MICROB <...

Bacterial RNA Isolation From Infected Eukaryotic Hosts

90% of mammalian RNA from complex mixtures of host-bacterial samples Seamless integration with MICROB <...

More>>

Euk at Biology Definition

Eukaryote

- Animals - Plants <a href="/ ?q=/ Bi...
Euk at Biology Dictionary

Leukocytes

: associations between the <a href="/ ?q=/ Biology-Dictionary/ cyanobacteri...

Eukaryotes

<A href="http:/ / users.rcn.com/ jkimball.ma...

Eukaryote

<a href="/ ?q=/ Biology-Dictionary/ genetics" cl...
Euk at Medicine News

GLEEVEC - An Oral treatment for leukemia

The U.S.Food and Drug Administration (FDA) at a conference in Washington, approves the new leukemia drug-GLEEVEC, first of its kind that directly removes the sign of a protein known to cause cancer. It is given as an oral treatment for chronic myelogenous leukemia (CML). Other molecular-targeting drugs previously approved by the FDA interfere with proteins associated with other cancer...

GLEEVEC - An Oral treatment for leukemia

The U.S.Food and Drug Administration (FDA) at a conference in Washington, approves the new leukemia drug-GLEEVEC, first of its kind that directly removes the sign of a protein known to cause cancer. It is given as an oral treatment for chronic myelogenous leukemia (CML). Other molecular-targeting drugs previously approved by the FDA interfere with proteins associated with other cancer...

Cyclosporin A Treats Leukemia Complications

Some leukemia patients with common complications of their disease may have a new way to overcome them. New research finds that chronic lymphocytic leukemia (CLL) patients with anemia or thrombocytopenia can be treated effectively with the drug, cyclosporin A. Anemia is a decrease in red cells in the blood and thrombocytopenia is when the number of platelets in reduced. The latter is the m...

Exposure to EMF may cause leukemia

Long periods of exposure to high level electromagnetic fields (EMF) at home could double the risk of childhood leukemia, a major international study has found. //The three-year review was carried out for the International Commission on Non-Ionizing Radiation Protection (ICNIRP) by six senior epidemiologists from major institutions around the world. Leukemia, which develops in the bone...

A new vaccine for leukemia

A new vaccine has been developed by a research team from Southampton University,which works by instigating the body's immune system to fight lymphoma,a cancer of the immune cells in the blood.//The lymphoma cells are not usually identified by the body's immune system, and so can multiply diversely. By, using the new technique, scientists are able to remove a sample of tumour ce...

More>>

Euk at Medicine Products

Blood Bank QC of Leukoreduced Products

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Chromosome Analysis, Chronic Lymphocytic Leukemia (CLL) Panel by FISH

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Chromosome Analysis, Leukemic Blood

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Chronic Lymphocytic Leukemia (CLL)

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

Fecal Leukocytes

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

More>>

Euk at Medicine Technology

Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia

First RNA Antagonist Medicine to Be Tested in Patients ReducesSeverity of Adult Leukaemia Copenhagen, 6th June 2007 - Santaris Pharma, the Danishbiopharmaceutical company, announced today that SPC2996, theCompany's new RNA Antagonist of Bcl-2, has shown early evidence ofefficacy in an initial Phase I/II clinical study in ChronicLymphocytic Leukaemia (CLL). The results of the study...

Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas

SAN CARLOS, Calif., June 05, 2007 /PRNewswire-FirstCall/ --Nuvelo, Inc. today announced the publication of data from apreclinical study of novel monoclonal antibodies against thecell-surface protein NTB-A. The data demonstrate that NTB-A is apotential new target for immunotherapy of B-cell malignanciesincluding leukemia and lymphomas. The study, entitled "The lymphoidcell surface recepto...

Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)

Preliminary Results of Largest Randomized, Placebo-controlled TrialEver Conducted in CTCL Presented at the American Society ofClinical Oncology CHICAGO, June 04, 2007 /PRNewswire/ -- Preliminary results ofthe largest randomized, placebo-controlled clinical trial everconducted in patients with cutaneous T-cell lymphoma (CTCL) showedthat ONTAK was more than twice as effective as placebo in...

Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report

CHICAGO, June 2, 2007 - An established second-linedrug for chronic myelogenous leukemia has high response rates whengiven to newly diagnosed patients as their first therapy for thedisease, according to early results from a Phase II clinical trialat The University of Texas M. D. Anderson Cancer Center. "Patients taking dasatinib achieve complete cytogenetic response- absence of the...

Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia

- Results from a Children's Oncology Group (COG) Study Presented atAmerican Society of Clinical Oncology Annual Meeting - CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Immunomedics,Inc. , a biopharmaceutical company focused on developing monoclonalantibodies to treat cancer and other serious diseases, todayannounced that treatment with epratuzumab plus standardchemotherapy is feasible...

More>>

Euk at Medicine Dictionary

Leukodystrophy

<a href="/ ?q=/ Medicin...

Leukopenia

counts are variable with age and sex. Normal adult range is 4,500 to 11,000 cells per cu...

Leukoplakia

<a href="/ ?q=/ Medic...

Leukemia

For information about a specific ty...

Leukocytes

<A href="http:/ / ww...

More>>

Other TagsFragmentFragmentFragmentMicroscopicMicroscopicAptamerRetroviralRetroviralPlanktonVietnamCompoundCompoundCompoundCompoundGifts
(Date:9/5/2008)...TA, Sept. 5 /PRNewswire/ -- EthicAd, a nonprofit o...ough consumer education, announces,the launch of a...ic better,understand direct-to-consumer (DTC) adve... Smart About Prescription Drug Advertising," is,ho...esearch and was,developed by the FDA in partnershi...
(Date:9/5/2008)...ton, DCWomen with hormone-receptor positive, metas... to help keep their cancer at bay, but when the tu...tment with chemotherapy becomes the only option. B... Cancer Symposiummay change this approach. Early ...sitize" the tumor, allowing anti-hormonal drugs to...
(Date:9/4/2008)...ork, NY, September 5, 2008Private Medicare Advanta... more per enrollee in 2008 compared to what the sa...icare fee-for-service program, according to a new ...yment reductions to MA plans mandated by the Medic... 2008 (MIPPA) scheduled to take effect beginning ...
(Date:9/4/2008)... want stronger labeling about fungal infection ris...) -- Federal health authorities have asked the man...rugs to bolster safety warnings on the risk of dev...drugs, Humira, Cimzia, Enbrel and Remicade, belong... factor alpha blockers (TNF-alpha blockers), which...
Breaking Medicine News(10 mins):Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2Health News:1 step back ... 2 steps forward 2Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3
(Date:9/5/2008)...eeding colonies of a critically endangered vulture...s of millions to a few thousand, are too small to ...of Michigan analysis shows. , Adding wild birds ...ndia, is crucial, but political and logistical bar... A. Johnson. , The study was published online Au...
(Date:9/5/2008)...of Hurricane Gustav is shown via a sequence of sat...ion Imaging Spectrometer (MERIS) instrument on 25 ...(from right to left). , Gustav formed on 25 Augu...aiti (seen above far right image), when a tropical...e feature (visible), causing the U.S. National Hur...
(Date:9/5/2008)...le in French and Spanish . , Researchers fro...Bromatology and Department of Chemistry-Physics ... study in which they have revealed the need of cou...n who follows Ramadan. , According to the collec...sumption levels are not appropriate if compared wi...
(Date:9/4/2008)... M.D. Anderson Cancer Center have developed a risk...y for African Americans that suggests a greater ri...D), according to a report published in the Septemb...l of the American Association for Cancer Research....African Americans with lung cancer and 497 African...
Breaking Biology News(10 mins):Recovery efforts not enough for critically endangered Asian vulture 2Recovery efforts not enough for critically endangered Asian vulture 3Hurricane Gustav 2Nutritionists of the UGR suggest diet improvements during Ramadan 2African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease 2Cavidi Signs Agreement With the Clinton Foundation HIV AIDS Initiative to Lower Costs of HIV Monitoring 7267 1Cavidi Signs Agreement With the Clinton Foundation HIV AIDS Initiative to Lower Costs of HIV Monitoring 7267 2Cavidi Signs Agreement With the Clinton Foundation HIV AIDS Initiative to Lower Costs of HIV Monitoring 7267 3Cell Therapeutics Inc Announces 246 5 Million Offering 7264 1Cell Therapeutics Inc Announces 246 5 Million Offering 7264 2Cell Therapeutics Inc Announces 246 5 Million Offering 7264 3Trojan 28R 29 and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 952 1Trojan 28R 29 and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 952 2Trojan 28R 29 and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 952 3Trojan 28R 29 and the National Sexuality Resource Centers Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 952 4AIDS Action Council Statement on World AIDS Day 2007 3A Leadership Needed for a National Strategy to Stop the AIDS Epidemic 949 1AIDS Action Council Statement on World AIDS Day 2007 3A Leadership Needed for a National Strategy to Stop the AIDS Epidemic 949 2
Other Contentsangiographyangiographyangiographyangiographyfluoresceinfluoresceinfluoresceinfluoresceinfolicfolicfolicfolatefolatefontanellesadditivesadditivesadditivesadditivesadditivesguideguideguideguideguideguideguideguideguidefracturesfracturesfracturesfractures